期刊文献+

心肌组织/硅基质微电极芯片技术对炙甘草汤含药血清作用于心肌电生理的研究 被引量:7

Effects of Zhigancao Decoction medicated serum combined with myocardial tissue / silicon substrate microelectrode technique on cardiac electrophysiology
下载PDF
导出
摘要 目的:现代药理研究证实,炙甘草汤总提物、单个有效成分及其配伍能明显减少心律失常的出现。文中旨在将血清药理学方法结合电生理技术研究炙甘草汤含药血清治疗心房颤动的机制。方法将新西兰大白兔分为正常对照组、正常血清对照组、炙甘草汤含药血清组、炙甘草汤水煎液组,每组8只。建立心房颤动动兔模型后,检测右心耳组织场电位时程( field action potential duration, fAPD),并观察炙甘草汤含药血清和水煎液对右心耳fAPD的作用。结果成功建立快速起搏右心房诱导心房颤动兔模型,起搏12 h后fAPD比起搏前明显缩短[(174.30±1.36)ms vs (162.48±0.88)ms, P<0.05]。给予10%、15%、20%、25%含药血清和水煎液之后,均可作用于心房颤动兔右心耳组织fAPD导致fAPD延长,量效成正相关。10%、15%、20%、25%含药血清组fAPD分别为[(170.81±0.61)、(171.00±0.46)、(179.08±0.67)、(179.76±2.26)ms]较水煎液组fAPD [(163.82±0.78)、(163.66±0.95)、(174.06±1.32)、(176.84±1.19)ms]延长明显(P<0.05)。结论 fAPD可作为心肌电生理特性改变的指标之一,10%~25%炙甘草汤含药血清可导致心房颤动兔fAPD延长可能是抗心房颤动发生的电生理机制。 Objective Modern pharmacological studies confirmed Zhigancao Decoction total extract, single active ingredients and their combinations could obviously inhibit arrhythmia.This study was to investigate the effects of Zhigancao Decoction medicated serum combined with myocardial tissue/silicon substrate microelectrode arrays (MEA) on rapid atrial pacing(RAP). Methods New Zealand white rabbits were randomly divided into normal control group, normal serum control group, Zhigancao Decoction medica-ted serum group and water decoction group, 8 in each group.After the establishment of an atrial fibrillation rabbit model, the field ac-tion potential duration ( fAPD) of the right atrial appendage ( RAA ) tissue was measured and the effections of Zhigancao Decoction medicated serum and water decoction on the fAPD of RAA were observed. Results The successful modeling of rapid atrial pacing induced atrial fibrillation in rabbits contributed to the significant shortening of fAPD 12 h after pacing compared to that before pacing ([174.30 ±1.36]ms vs[162.48 ±0.88]ms, P〈0.05).After giving 10%~25% Zhigancao Decoction medicated serum and water decoction, the fAPDs of RAA tissue in rabbits with atrial fibrillation were prolonged, which represented positive dose-response relation-ship.The fAPDs of the rabbits given serum containing 10%, 15%, 20%and 25%Zhigancao Decoction were respectively (170.81 ± 0.61)ms, (171.00 ±0.46)ms, (179.08 ±0.67)ms, (179.76 ±2.26)ms, which were longer than those of water decoction group ([163.82 ±0.780]ms, [163.66 ±0.95]ms, [174.06 ±1.32]ms, [176.84 ±1.19]ms), and the difference was statistically sig-nificant (P〈0.05). Conclusion The fAPD can be taken as one index of cardiac electrophysiological change, and 10%~25%Zh-igancao Decoction medicated serum can lead to fAPD extension in rabbit model of atrial fibrillation, which might be the electrophysio-logical mechanism of anti-atrial fibrillation.
出处 《医学研究生学报》 CAS 北大核心 2014年第11期1160-1163,共4页 Journal of Medical Postgraduates
基金 新疆维吾尔自治区自然科学基金(2012211A064)
关键词 快速起搏右心房 心房颤动 微电极芯片 炙甘草汤 含药血清 Rapid atrial pacing Atrial fibrillation Microelectrode arrays Zhigancao Decoction Medicated serum
  • 相关文献

参考文献20

二级参考文献173

共引文献322

同被引文献146

  • 1王智,徐瑞鑫.炙甘草汤加减对急性心肌缺血大鼠心电图和血清酶学指标的影响[J].中国老年学杂志,2014,34(11):3083-3085. 被引量:11
  • 2殷明伟,刘敏.特发性肺纤维化的中医辨证治疗探讨[J].浙江中医杂志,2007,42(7):414-415. 被引量:16
  • 3周承志,张道亮,王腾,唐其柱,邱明义.炙甘草汤含药血清对兔心肌细胞钙电流的影响[J].北京中医药大学学报,2007,30(7):468-471. 被引量:40
  • 4Fuster V, Ryd6n LE, Cannom DS, et al. 2011 ACCF/AHA/ HRS focused updates incorporated into the ACC/AHA/ESC 2006 Guidelines for the management of patients with atrial fibril- lation: a report of the American College of Cardiology Founda- tion/American Heart Association Task Force on Practice Guide- lines developed in partnership with the European Society of Car- diolagy and in collaboration with the European Heart Rhythm As- sociation and the Heart Rhythm Society[J]. J Am Coll Cardiol, 2011, 57(11) : e101-e198.
  • 5Carom AJ, Lip GY, De Caterina R, et al. 2012 focused update of the esc guidelines for the management of atrial fibrillation : An update of the 2010 esc guidelines for the management of atrial fi- brillation--developed with the special contribution of the european heart rhythm association[J]. Eurepace, 2012, 14(10) : 1385- 1413.
  • 6Connolly SJ, Ezekowitz MD, Yusuf S, et al. Dabigatran versus warfarin in patients with atrial fibrillation [ J ]. N Engl J Med, 2009, 361(12) : 1139-1151.
  • 7Granger CB, Alexander JH, McMurray JJ, et al. Apixaban ver- sus warfarin in patients with atrial fibrillation [ J ]. N Engl J Med, 2011, 365(11): 981-992.
  • 8Patel MR, Mabaffey KW, Garg J, et al. Rivaroxaban versus war- farin in nonvalvular atrial fibrillation[J]. N Engl J Med, 2011, 365(10) : 883-891.
  • 9Bartus K, Han FT, Bednarek J, et al. Pereutaneous left atrial appendage suture ligation using the LARIAT device in patients with atrial fibrillation: initial clinical experience [J]. J Am Coil Cardiol, 2013, 62: 108-118.
  • 10Cruz-Gonzalez I, Yan BP, Lam YY. Left atrial appendage exclu- sion : State-of-the-art[ J]. Catheter Cardiovasc Interv, 2010, 75 (5) : 806-813.

引证文献7

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部